BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29098910)

  • 1. Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients.
    Baur J; Mathe K; Gesierich A; Weyandt G; Wiegering A; Germer CT; Pelz JOW
    J Dermatolog Treat; 2018 Aug; 29(5):515-521. PubMed ID: 29098910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients.
    Baur J; Mathe K; Gesierich A; Weyandt G; Wiegering A; Germer CT; Gasser M; Pelz JOW
    World J Surg Oncol; 2017 May; 15(1):99. PubMed ID: 28490340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity of Staging Inframesenteric Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer Compared With Infrarenal Lymphadenectomy.
    Petitnicolas C; Azaïs H; Ghesquière L; Tresch-Bruneel E; Cordoba A; Narducci F; Bresson L; Leblanc E
    Int J Gynecol Cancer; 2017 Mar; 27(3):575-580. PubMed ID: 28166115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical lymph node dissection for melanoma.
    Serpell JW; Carne PW; Bailey M
    ANZ J Surg; 2003 May; 73(5):294-9. PubMed ID: 12752285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
    Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis.
    Mandel P; Tilki D; Eslick GD
    Urol Oncol; 2014 Nov; 32(8):1184-90. PubMed ID: 25027683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Morbidity with Extent of Lymphadenectomy for Primary Malignant Melanoma.
    Renner P; Torzewski M; Zeman F; Babilas P; Kroemer A; Schlitt HJ; Dahlke MH
    Lymphat Res Biol; 2017 Jun; 15(2):146-152. PubMed ID: 28617648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
    Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
    Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center.
    Lamboo LG; Haydu LE; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Bonenkamp JJ; Thompson JF
    Ann Surg; 2014 Dec; 260(6):1095-102. PubMed ID: 25072430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.